StonvexLoading…
StonvexStonvexStonvexCore line items from VSAT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $4.52B | $4.28B | $2.56B | $2.42B |
Operating Income | $-97.48M | $-889.81M | $-155.96M | $-113.14M |
Net Income | $-574.96M | $-1.07B | $1.08B | $-15.53M |
EPS (Diluted) | $-4.48 | $-9.12 | $14.29 | $-0.21 |
Total Assets | $15.45B | $16.33B | $7.73B | $6.39B |
Total Liabilities | $10.80B | $11.26B | $3.87B | $3.71B |
Cash & Equivalents | $1.61B | $1.90B | $1.35B | $310.46M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-709.11M | $-432.64M |
Shares Outstanding | 130.21M | 125.85M | 76.91M | 74.43M |